BIMU 8 – 5 mg

Brand:
Cayman
CAS:
134296-40-5
Storage:
-20
UN-No:
Non-Hazardous - /

BIMU 8 is an agonist of the serotonin (5-HT) receptor subtype 5-HT4 (Ki = 69 nM).{58017} It also binds 5-HT3 receptors (Ki = 0.36 nM). It stimulates cAMP formation in primary mouse embryonic colliculi neurons with an EC50 value of 72 nM.{58018} BIMU 8 (30, 40, and 60 nmol/animal, i.c.v.) induces acetylcholine release in the rat frontal cortex.{58019} It increases postprandial antral and colonic motility in conscious dogs when administered at doses of 0.1, 0.3, and 1 mg/kg.{39019} BIMU 8 (20 mg/kg, i.p.) also increases the latency to withdraw in the paw pressure test in rats.{58020}  

 

Available on backorder

SKU: 30964 - 5 mg Category:

Description

A 5-HT4 receptor agonist (Ki = 69 nM); also binds 5-HT3 receptors (Ki = 0.36 nM); stimulates cAMP formation in primary mouse embryonic colliculi neurons (EC50 = 72 nM); induces acetylcholine release in the rat frontal cortex at 30, 40, and 60 nmol/animal; increases postprandial antral and colonic motility in conscious dogs at 0.1, 0.3, and 1 mg/kg; increases the latency to withdraw in the paw pressure test in rats at 20 mg/kg


Formal name: 2,3-dihydro-N-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]-3-(1-methylethyl)-2-oxo-1H-benzimidazole-1-carboxamide, monohydrochloride

Synonyms: 

Molecular weight: 378.9

CAS: 134296-40-5

Purity: ≥98%

Formulation: A solid